| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |